SG/CALL/EDWARDS LIFESCIENCES/65/0.1/20.12.24 | Delayed Deutsche Boerse AG 09:35:50 2024-06-07 EDT | ||
| 2.42 EUR | -1.63% |
|
| Current month | +4.24% | ||
| 1 month | +1.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 2.42 | -1.63% |
| 24-06-06 | 2.46 | +2.93% |
| 24-06-05 | 2.39 | -1.65% |
| 24-06-04 | 2.43 | -2.41% |
| 24-06-03 | 2.49 | +5.51% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 09:35 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SU2MAL |
| ISIN | DE000SU2MAL1 |
| Date issued | 2023-11-22 |
| Strike | 65 $ |
| Maturity | 2024-12-20 (196 Days) |
| Parity | 10 : 1 |
| Emission price | 1.55 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.42 € |
|---|---|
| Lowest since issue | 1.42 € |
| Spread | 0.01 € |
| Spread % | 0.41% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.68
USD
Average target price
96.31
USD
Spread / Average Target
+9.84%
- Stock Market
- Warrants
- Warrant
